Neurological Therapy Company Secures Major Technology Development
Helius Medical Technologies Secures HCPCS Codes for PoNS® Device: A Groundbreaking Development in Neurological Therapy.
All information provided in this article is accurate, factual and up-to-date.
In a ground-breaking advancement for neurological therapy, Helius Medical Technologies, Inc. (NASDAQ: HSDT) has secured Healthcare Common Procedure Coding System (HCPCS) codes for its Portable Neuromodulation Stimulator (PoNS®) device.
Helius Medical Technologies is a neurotech company focused on neurological wellness. Their pioneering product, the PoNS® device, is a non-invasive means for delivering neurostimulation through the tongue.
The HCPCS is a standardized coding system that doctors, insurers, and other healthcare workers use to classify medical diagnoses, procedures, and equipment. By obtaining these codes, Helius Medical Technologies will enhance the accessibility of the PoNS® device for patients, as it could pave the way for insurance coverage.
The PoNS® Device: A Revolutionary Leap in Neurological Wellness
The PoNS® device is an innovative, non-invasive method for delivering neurostimulation via the tongue. It's designed to aid the recovery of balance and gait in patients with mild to moderate Traumatic Brain Injury (TBI), or who have issues due to neurological disease.
The PoNS® device works by stimulating the neural network through patterns of electric pulses with specifically set frequency, pulse width, and amplitude. This stimulation, when combined with targeted physical therapies, can lead to significant improvements in balance and gait functionality.
Implications of the HCPCS Codes for Helius Medical Technologies
The acquisition of the HCPCS codes is a significant milestone for Helius Medical Technologies. These codes could potentially facilitate reimbursement from Medicare, Medicaid, and private insurance providers, thereby making the PoNS® device more accessible to patients.
Looking Ahead
The securing of the HCPCS codes is a promising step forward for Helius Medical Technologies and the patients who can benefit from the PoNS® device. With these codes, the company is poised to make their innovative device more accessible to those in need.
This development could have significant implications for the field of neurological therapy, potentially changing the lives of countless patients struggling with balance and gait issues due to TBI or neurological disease.
The future looks bright for Helius Medical Technologies as they continue to pave the way for advances in neurotech. As always, we'll keep you updated with the latest developments.
As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.
Sources: